Avirmax Biopharma Inc. Will Present at the 26th ASGCT 2023 Annual Conference in Los Angeles

HAYWARD, Calif., May 17, 2023 /PRNewswire/ -- Avirmax Biopharma Inc. (ABI), Chief Executive and Scientific Officer, Shengjiang Shawn Liu will present results of a three-year study that systematically compared the recombinant adeno-associated virus (rAAV) vector products manufactured using...

Click to view original post